Endpoints for Validation of Tumour Markers for Recurrence Risk - Recurrence-free Interval (RFI), Disease-free Survival (DFS), Overall Survival (OS), and Colon-cancer Specific Survival (CCSS) in CALGB 9581

被引：0
|
作者：
Mahmoud, N. N. [1 ]
Lopatin, M. [2 ]
Clark-Langone, K. [2 ]
Lee, M. [2 ]
Niedzwiecki, D. [3 ]
Venook, A. P. [4 ]
机构：
[1] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA
[2] Genom Hlth Inc, Med Oncol, Redwood City, CA USA
[3] Duke Univ, Durham, NC USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)70904-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [31] Importance of pelvic and para-aortic Lymphadenectomy for Overall survival and recurrence-free survival in Ovarian Cancer.
    Bachmann, C.
    Bachmann, S.
    Solomayer, E.
    Wallwiener, D.
    ONKOLOGIE, 2010, 33 : 111 - 111
  • [32] Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients
    Woods, Nicholas T.
    Monteiro, Alvaro N.
    Thompson, Zachary J.
    Amankwah, Ernest K.
    Naas, Nina
    Haura, Eric B.
    Beg, Amer A.
    Schabath, Matthew B.
    MOLECULAR CARCINOGENESIS, 2015, 54 : E172 - E184
  • [33] Conditional recurrence analysis of intrahepatic cholangiocarcinoma: Changes in recurrence rate and survival after recurrence resection by disease-free interval
    Maki, Harufumi
    Kawaguchi, Yoshikuni
    Nagata, Rihito
    Mihara, Yuichiro
    Ichida, Akihiko
    Ishizawa, Takeaki
    Akamatsu, Nobuhisa
    Kaneko, Junichi
    Arita, Junichi
    Hasegawa, Kiyoshi
    HEPATOLOGY RESEARCH, 2023, 53 (12) : 1224 - 1234
  • [34] Overall survival (OS) and updated disease-free survival (DFS) results of the NSABP C-08 trial assessing bevacizumab (B) in stage II and III colon cancer
    Allegra, C. J.
    Yothers, G. A.
    O'Connell, M. J.
    Sharif, S.
    Petrelli, N. J.
    Colangelo, L. H.
    Wolmark, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] INFLUENCE OF METABOLIC SYNDROME ON OVERALL SURVIVAL (OS), DISEASE FREE SURVIVAL (DFS) AND INVASIVE FREE SURVIVAL (IFV) IN A COHORT OF PATIENTS TREATED FOR BREAST CANCER IN BRAZIL
    Antonini, Marcelo
    Guimaraes, Amanda Leal
    Richter, Fernanda Grace Bauk
    Ferraro, Odair
    Lopes, Reginaldo G. Coelho
    Real, Juliana M.
    Mattar, Andre
    CANCER RESEARCH, 2023, 83 (05)
  • [36] External validation of a nomogram predicting disease-free (DFS) and overall survival (OS) in patients (pts) with primary retroperitoneal sarcoma (pRPS)
    Raut, C.
    Miceli, R.
    Strauss, D.
    Swallow, C.
    Hohenberger, P.
    Van Coevorden, F.
    Rutkowski, P.
    Fiore, M.
    Callegaro, D.
    Casali, P.
    Haas, R.
    Hayes, A.
    Honore, C.
    Cannell, A.
    Jakob, J.
    Szacht, M.
    Fairweather, M.
    Pollock, R.
    Bonvalot, S.
    Gronchi, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S689 - S690
  • [37] Prognostic Factors Affecting Disease-Free Survival and Overall Survival in T4 Colon Cancer
    Eom, Taeyeong
    Lee, Yujin
    Kim, Jungbin
    Park, Inseok
    Gwak, Geumhee
    Cho, Hyunjin
    Yang, Keunho
    Kim, Kiwhan
    Bae, Byung-Noe
    ANNALS OF COLOPROCTOLOGY, 2021, 37 (04) : 259 - 265
  • [38] DISEASE-FREE SURVIVAL (DFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN ADULTS WITH RESECTABLE ESOPHAGEAL OR GASTROESOPHAGEAL JUNCTION CANCER: A CORRELATION META-ANALYSIS
    Leung, L.
    Kurt, M.
    Singh, P.
    Kim, I
    Donnellan, G.
    Kanters, S.
    VALUE IN HEALTH, 2021, 24 : S1 - S1
  • [39] Disease-free survival (DFS) as a predictor of overall survival (OS) in completely resected early stage non-small cell lung cancer (NSCLC)
    West, H.
    Hu, X.
    Burke, T.
    Walker, M. S.
    Wang, Y.
    Samkari, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S74 - S75
  • [40] Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients
    Qian, Jinrong
    Zeng, Lifeng
    Jiang, Xiaohua
    Zhang, Zhiyong
    Luo, Xiaojiang
    MEDICAL SCIENCE MONITOR, 2019, 25 : 7258 - 7271
12345